BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11236855)

  • 1. Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings.
    Giesler RB; Miles BJ; Cowen ME; Kattan MW
    Qual Life Res; 2000; 9(6):645-65. PubMed ID: 11236855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.
    Litwin MS; Hays RD; Fink A; Ganz PA; Leake B; Brook RH
    Med Care; 1998 Jul; 36(7):1002-12. PubMed ID: 9674618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimensions of quality of life expressed by men treated for metastatic prostate cancer.
    Clark JA; Wray N; Brody B; Ashton C; Giesler B; Watkins H
    Soc Sci Med; 1997 Oct; 45(8):1299-309. PubMed ID: 9381242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of patient preferences among men with prostate cancer.
    Albertsen PC; Nease RF; Potosky AL
    J Urol; 1998 Jan; 159(1):158-63. PubMed ID: 9400461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
    Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
    Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-cultural validation of the UCLA prostate cancer index.
    Karakiewicz PI; Kattan MW; Tanguay S; Elhilali MM; Bazinet M; Scardino PT; Aprikian AG
    Urology; 2003 Feb; 61(2):302-7. PubMed ID: 12597935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assessed health-related quality of life in men who have completed radiotherapy for prostate cancer: instrument validation and its relation to patient-assessed bother of symptoms.
    Wang H; Huang E; Dale W; Campbell T; Ignacio L; Kopnick M; Ray P; Vijayakumar S
    Int J Cancer; 2000 Jun; 90(3):163-72. PubMed ID: 10900429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: instrument validation and its relation to patient-assessed bother of symptoms.
    Dale W; Campbell T; Ignacio L; Song P; Kopnick M; Mamo C; Ray P; Vijayakumar S
    Urology; 1999 Feb; 53(2):359-66. PubMed ID: 9933055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30.
    Borghede G; Sullivan M
    Qual Life Res; 1996 Apr; 5(2):212-22. PubMed ID: 8998490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer.
    Gilbert SM; Dunn RL; Hollenbeck BK; Montie JE; Lee CT; Wood DP; Wei JT
    J Urol; 2010 May; 183(5):1764-9. PubMed ID: 20299056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric Validation of the Sexual Distress Scale in Men with Prostate Cancer.
    Santos-Iglesias P; Walker LM
    J Sex Med; 2018 Jul; 15(7):1010-1020. PubMed ID: 29960626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an instrument to assess the needs of men diagnosed with prostate carcinoma: an assessment of the validity and reliability of a self-administered questionnaire developed to measure the needs experienced by men diagnosed with prostate carcinoma.
    Duke JM; Treloar CJ; Byles JE
    Cancer; 2003 Feb; 97(4):993-1001. PubMed ID: 12569598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development.
    Befort CA; Zelefsky MJ; Scardino PT; Borrayo E; Giesler RB; Kattan MW
    Clin Prostate Cancer; 2005 Sep; 4(2):100-8. PubMed ID: 16197610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.
    Hollen PJ; Gralla RJ; Kris MG; Cox C; Belani CP; Grunberg SM; Crawford J; Neidhart JA
    Cancer; 1994 Apr; 73(8):2087-98. PubMed ID: 8156514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of ESCAP-CD as an instrument of measure for the evaluation of the quality of life in prostatic cancer. Part 2a].
    Morales López A; Grau Fibla G; Campoy Martínez P; Benavente Rodríguez A; Pascual del Pobil Moreno JL
    Actas Urol Esp; 2002 May; 26(5):320-34. PubMed ID: 12174740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Patient-Reported Outcomes Thermometer-5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases.
    Salaffi F; Di Carlo M; Carotti M; Farah S
    Pain Res Manag; 2018; 2018():3496846. PubMed ID: 30425755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire.
    Stockler MR; Osoba D; Corey P; Goodwin PJ; Tannock IF
    J Clin Epidemiol; 1999 Jul; 52(7):653-66. PubMed ID: 10391659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.